Suchergebnisse - "Molvi, Zaki"

PubPharm (14)

1

The resting state of the human T-cell receptor–CD3 complex

enthalten in: bioRxiv.org | 2024

von Notti, R. | Yi, F. | Heissel, S. | +5

2

The resting state of the human T-cell receptor-CD3 complex

enthalten in: bioRxiv : the preprint server for biology | 2024

von Notti, R. | Yi, F. | Heissel, S. | +5

3

Challenges and solutions for therapeutic TCR-based agents

enthalten in: Immunological reviews | 2023

von Malviya, M. | Aretz, Z. | Molvi, Z. | +5

4

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

enthalten in: Journal for immunotherapy of cancer | 2023

von Molvi, Z. | Klatt, M. | Dao, T. | +3

UpdateOf: bioRxiv. 2023 Feb 12;:. - PMID 36798179

5

Cytomegalovirus-specific T cells following haploidentical transplants : reshaping a repertoire by half

enthalten in: Haematologica | 2023

von O'Reilly, R. | Molvi, Z.

CommentOn: Haematologica. 2023 Jun 01;108(6):1530-1543. - PMID 36200418

6

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

enthalten in: bioRxiv.org | 2023

von Molvi, Z. | Klatt, M. | Dao, T. | +3

7

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

enthalten in: bioRxiv : the preprint server for biology | 2023

von Molvi, Z. | Klatt, M. | Dao, T. | +3

UpdateIn: J Immunother Cancer. 2023 Sep;11(9):. - PMID 37775115

8

Challenges and solutions for therapeutic TCR‐based agents

enthalten in: Immunological Reviews | 2023

von Malviya, M. | Aretz, Z. | Molvi, Z. | +5

9

Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment

enthalten in: Blood advances | 2022

von Bourne, C. | Mun, S. | Dao, T. | +8

10

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

enthalten in: Science translational medicine | 2022

von Gigoux, M. | Holmström, M. | Zappasodi, R. | +40